BACKGROUND: The prevalence of peripheral arterial occlusive disease (PAOD), including asymptomatic cases and cases unknown to the general practitioner (GP) was estimated in 18,884 men and women, aged 45-74 years, on the list of 18 general practice centres (GPC). METHODS: The study population (n = 3171) consisted of a stratified sample of the total population. In the GPC data were collected on intermittent claudication (IC), peripheral pulses, vascular risk factors, cardio- and cerebrovascular disease (CCVD) and the ankle brachial systolic pressure ratio (AB ratio) and PAOD was defined as an AB ratio < 0.95 on two consecutive occasions. Results were recalculated for the total population. RESULTS: The prevalence of PAOD was 6.9 percent (95 percent Cl:5.2-7.9 percent), a quarter of which (1.6 percent) met the classic WHO criteria. Peripheral arterial occlusive disease did not occur significantly more often among men than among women but men suffered more often from an advanced stage of PAOD. Of all PAOD cases, 22 percent were symptomatic. The proportion of symptomatic cases correlated positively with higher age, male gender and lower AB ratio. Among asymptomatic PAOD cases the prevelance of concomitant CCVD was three to four times as high as in the group of subjects without PAOD. Of all PAOD cases 68 percent were unknown to the GP and this group mainly represented less advanced cases of atherosclerosis. However, among PAOD cases with an AB ratio <0.75, 42 percent were unknown to the GP. CONCLUSIONS: Our data on asymptomatic and unknown PAOD cases show that GPs can still enhance their efforts towards (secondary) prevention of atherosclerosis.
BACKGROUND: The prevalence of peripheral arterial occlusive disease (PAOD), including asymptomatic cases and cases unknown to the general practitioner (GP) was estimated in 18,884 men and women, aged 45-74 years, on the list of 18 general practice centres (GPC). METHODS: The study population (n = 3171) consisted of a stratified sample of the total population. In the GPC data were collected on intermittent claudication (IC), peripheral pulses, vascular risk factors, cardio- and cerebrovascular disease (CCVD) and the ankle brachial systolic pressure ratio (AB ratio) and PAOD was defined as an AB ratio < 0.95 on two consecutive occasions. Results were recalculated for the total population. RESULTS: The prevalence of PAOD was 6.9 percent (95 percent Cl:5.2-7.9 percent), a quarter of which (1.6 percent) met the classic WHO criteria. Peripheral arterial occlusive disease did not occur significantly more often among men than among women but men suffered more often from an advanced stage of PAOD. Of all PAOD cases, 22 percent were symptomatic. The proportion of symptomatic cases correlated positively with higher age, male gender and lower AB ratio. Among asymptomatic PAOD cases the prevelance of concomitant CCVD was three to four times as high as in the group of subjects without PAOD. Of all PAOD cases 68 percent were unknown to the GP and this group mainly represented less advanced cases of atherosclerosis. However, among PAOD cases with an AB ratio <0.75, 42 percent were unknown to the GP. CONCLUSIONS: Our data on asymptomatic and unknown PAOD cases show that GPs can still enhance their efforts towards (secondary) prevention of atherosclerosis.
Authors: Bianca Lw Bendermacher; Joep Aw Teijink; Edith M Willigendael; Marie-Louise Bartelink; Harry R Büller; Ron Jg Peters; Jelis Boiten; Machteld Langenberg; Martin H Prins Journal: Br J Gen Pract Date: 2006-12 Impact factor: 5.386
Authors: Nima Toosizadeh; Hannah Stocker; Rebecca Thiede; Jane Mohler; Joseph L Mills; Bijan Najafi Journal: Vasc Med Date: 2016-09-15 Impact factor: 3.239
Authors: María Teresa Alzamora; Rosa Forés; José Miguel Baena-Díez; Guillem Pera; Pere Toran; Marta Sorribes; Marisa Vicheto; María Dolores Reina; Amparo Sancho; Carlos Albaladejo; Judith Llussà Journal: BMC Public Health Date: 2010-01-27 Impact factor: 3.295
Authors: P Cacoub; J-P Cambou; S Kownator; J-P Belliard; J-P Beregi; A Branchereau; P Carpentier; P Léger; F Luizy; D Maïza; E Mihci; M-A Herrmann; P Priollet Journal: Int J Clin Pract Date: 2009-01 Impact factor: 2.503